DK1470829T3 - Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse - Google Patents

Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse

Info

Publication number
DK1470829T3
DK1470829T3 DK04007897T DK04007897T DK1470829T3 DK 1470829 T3 DK1470829 T3 DK 1470829T3 DK 04007897 T DK04007897 T DK 04007897T DK 04007897 T DK04007897 T DK 04007897T DK 1470829 T3 DK1470829 T3 DK 1470829T3
Authority
DK
Denmark
Prior art keywords
preparation
pore system
antibiotic
coating
porous body
Prior art date
Application number
DK04007897T
Other languages
Danish (da)
English (en)
Inventor
Sebastian Dr Vogt
Matthias Dr Schnabelrauch
Klaus-Dieter Dr Kuehn
Original Assignee
Heraeus Kulzer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh filed Critical Heraeus Kulzer Gmbh
Application granted granted Critical
Publication of DK1470829T3 publication Critical patent/DK1470829T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04007897T 2003-04-25 2004-04-01 Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse DK1470829T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10318991A DE10318991A1 (de) 2003-04-25 2003-04-25 Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung

Publications (1)

Publication Number Publication Date
DK1470829T3 true DK1470829T3 (da) 2008-01-21

Family

ID=32946448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04007897T DK1470829T3 (da) 2003-04-25 2004-04-01 Poröst legeme med antibiotisk coating, fremgangsmåde til fremstilling samt anvendelse

Country Status (16)

Country Link
US (1) US20050031664A1 (fr)
EP (1) EP1470829B1 (fr)
JP (1) JP2004321804A (fr)
CN (1) CN1569257A (fr)
AT (1) ATE378077T1 (fr)
AU (1) AU2004200955B2 (fr)
BR (1) BRPI0401467A (fr)
CA (1) CA2459619C (fr)
CY (1) CY1108043T1 (fr)
DE (2) DE10318991A1 (fr)
DK (1) DK1470829T3 (fr)
ES (1) ES2294388T3 (fr)
PL (1) PL1470829T3 (fr)
PT (1) PT1470829E (fr)
SI (1) SI1470829T1 (fr)
ZA (1) ZA200403113B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007502861A (ja) * 2003-05-01 2007-02-15 レプリダイン・インコーポレーテッド 抗菌方法及び組成物
DE102006016598A1 (de) * 2006-04-06 2007-11-15 Heraeus Kulzer Gmbh Beschichtete Vaskulärimplantate
DE102007039871A1 (de) * 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Weichgewebe-Implantat mit antibakterieller Wirkung
DE102010020940B4 (de) 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
DE102010055559B4 (de) 2010-12-23 2015-10-29 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung
DE102010055561B4 (de) 2010-12-23 2015-12-31 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung
DE102010055560B4 (de) 2010-12-23 2017-02-23 Heraeus Medical Gmbh Beschichtungsvorrichtung
DE102010055562B4 (de) 2010-12-23 2015-07-09 Heraeus Medical Gmbh Beschichtungsvorrichtung und Beschichtungsverfahren
DE102011117526B4 (de) 2011-11-03 2015-07-30 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung für medizinische Implantate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) * 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
FR1468638A (fr) * 1963-10-22 1967-02-10 Roussel Uclaf Sels de l'acide fusidique et procédé de préparation
DE2442021A1 (de) * 1974-09-03 1976-03-18 Bayer Ag Verfahren zur herstellung poroeser koerper auf der basis von gips, insbesondere anhydrit
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
GB2093348B (en) * 1981-02-23 1984-09-12 Leo Pharm Prod Ltd Pharmaceutical composition for implantation
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
DE4314871A1 (de) * 1993-05-05 1994-11-10 Merck Patent Gmbh Lösungsmittel für ein schwerlösliches Gentamicin-Salz
DE19856668A1 (de) * 1998-12-09 2000-06-15 Aesculap Ag & Co Kg Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung
DE10114245A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
DE10227935B4 (de) * 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung

Also Published As

Publication number Publication date
ATE378077T1 (de) 2007-11-15
CA2459619C (fr) 2008-08-12
AU2004200955A1 (en) 2004-11-11
EP1470829A1 (fr) 2004-10-27
ZA200403113B (en) 2004-11-05
EP1470829B1 (fr) 2007-11-14
SI1470829T1 (sl) 2008-04-30
US20050031664A1 (en) 2005-02-10
CA2459619A1 (fr) 2004-10-25
CY1108043T1 (el) 2013-09-04
CN1569257A (zh) 2005-01-26
PL1470829T3 (pl) 2008-06-30
JP2004321804A (ja) 2004-11-18
DE502004005462D1 (de) 2007-12-27
DE10318991A1 (de) 2004-11-18
PT1470829E (pt) 2007-12-26
BRPI0401467A (pt) 2005-01-18
AU2004200955B2 (en) 2007-05-24
ES2294388T3 (es) 2008-04-01

Similar Documents

Publication Publication Date Title
CY1108043T1 (el) Πορωδη σωματα με αντιβιοτικη επικαλυψη, μεθοδος παραγωγης και χρηση
ZA200304798B (en) Antibiotic coating of porous bodies and method for manufacture thereof and use thereof.
BRPI0506744A (pt) membrana de compósito de metal paládio ou membrana de compósito de liga de paládio e seus métodos de preparação
WO2007062306A3 (fr) Procede permettant de revetir des surfaces d'un agent antimicrobien
WO2007050546A3 (fr) Dispositifs et methodes pour traiter une regurgitation de la valvule mitrale
ZA200710732B (en) Method and composition to control the growth of micro-organisms in aqueous systems and on substrates
MX2007005711A (es) Composicion antibacterial y metodos de la misma.
ATE389043T1 (de) Verfahren zur beschichtung eines substrates mit calciumphosphat
RU2010138931A (ru) Способ и устройство для определения анализируемого вещества
DE602005024575D1 (de) Biomimetisches verfahren zur beschichtung von substraten
BRPI0606574A2 (pt) métodos de ativação de um revestimento orgânico e de preparação de um tratamento de ativação, substrato revestido e tratamento de ativação para um revestimento orgânico
DE602004026323D1 (de) Verbesserung der uberlebensfähigkeit von kryokonserviertem biologischem material nach dem auftauen durch provokation mit hydrostatischem druck
DE502004003920D1 (de) Verfahren zur Herstellung von wasserdispergierbaren Celluloseether mit vermindertem Glyoxalgehalt
ATE553852T1 (de) Verfahren zum teilweisen beschichten eines werkstückes
TW200730248A (en) Palladium complex and catalyst-imparting treatment solution using the same
BR0301708A (pt) Preparação farmacêutica com liberação de substância ativas retardada, processo para produção e uso da mesma
PL2110420T3 (pl) Sposób nanoszenia na podłoże zestawu zwiększającego przyczepność
ATE283767T1 (de) Verfahren zur beschichtung eines bewegten trägers
WO2008045766A3 (fr) Procédé pour le traitement de la peau
WO2006044307A3 (fr) Systeme de levitation magnetique pour revetir un dispositif, procede d'utilisation du systeme et dispositif produit par le systeme
EP1953554A3 (fr) Procédé de production d'un substrat immobilisé à substance active physiologiquement
DE602004012927D1 (de) Beschichtungsvorrichtung und Verfahren
WO2008053492A3 (fr) Système et procédé pour traiter le tissu
ATE487945T1 (de) Verfahren zum konservieren von humanem zellmembranantigen
CO2022002612A2 (es) Una composición farmacéutica para el tratamiento tópico de heridas.